Revenue: The sum of all revenue fields included for a company's operating activities.
ARYx Therapeutics Inc. (ARYX) Revenue data is not available for the most recently reported fiscal quarter, ending 2010-09-30.
| Income Statement Financials | |
|
Revenue |
-- |
$-2.51M |
|
-- |
|
-- |
|
$2.15M |
|
$-2.15M |
|
$-0.37M |
|
$-2.51M |
|
$-2.51M |
|
$-2.51M |
|
$-2.51M |
|
$-2.51M |
|
$-2.51M |
|
$-2.15M |
|
$-1.94M |
|
33.46M |
|
33.46M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$3.68M |
|
$1.58M |
|
$2.29M |
|
$5.97M |
|
$7.79M |
|
$4.75M |
|
$5.92M |
|
$13.71M |
|
$-7.74M |
|
$-7.74M |
|
$-7.74M |
|
33.46M |
|
| Cash Flow Statement Financials | |
$-13.98M |
|
$0.85M |
|
$8.68M |
|
$7.41M |
|
$2.95M |
|
$-4.46M |
|
$0.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.47 |
|
-- |
|
-- |
|
-1.59 |
|
-1.50 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-13.99M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
32.50% |
|
32.50% |
|
-42.10% |
|
84.16% |
|
$-0.23 |
|
$-0.42 |
|
$-0.42 |
|